18
Participants
Start Date
January 20, 2014
Primary Completion Date
March 24, 2014
Study Completion Date
March 24, 2014
ALXN1840
ALXN1840 (60 milligrams) was administered orally as non-coated capsules at Hour 0 on Day 1.
Omeprazole
Omeprazole (20 milligrams) was administered orally as a delayed-release capsule in the morning of Days -5 to -1 and at Hour -1 on Day 1.
Clinical Trial Site, Lincoln
Lead Sponsor
Alexion Pharmaceuticals, Inc.
INDUSTRY